Cerebrospinal fluid lysozyme in the diagnosis of tuberculous meningitis.

Pretreatment lysozyme levels in cerebrospinal fluid (CSF) were estimated in 37 patients with tuberculous meningitis (TBM), 16 with non-tuberculous meningitis (non-TBM) and 13 with non-inflammatory conditions of the central nervous system (controls) in an attempt to assess the role of CSF lysozyme in the diagnosis of TBM. Lysozyme content in the CSF was found to be elevated in all patients with bacteriologically confirmed TBM and in a large proportion of patients in whom the disease was clinically diagnosed but bacteriologically not confirmed. The enzyme was not detected in all but one of the control subjects and in most (69%) of the non-TBM patients.